Loading company…
Phenex Pharmaceuticals AG, based in Ludwigshafen, develops treatments for oncology and autoimmune diseases.
Founded in 2002 and headquartered in Ludwigshafen, Germany, Phenex Pharmaceuticals AG develops treatments for unmet medical needs in oncology and autoimmune diseases. In January 2015 Gilead Sciences acquired its Farnesoid X Receptor (FXR) program for up to USD 470 million. The company has completed six deals, most recently a Series D round in which it raised EUR 5.000 mn from investors including CD-Venture and Creathor Ventures.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in